Harmouche Majid, Loreille Frederic, Le Bars Florent, Marchand Etienne, Aupart Michel, Martinez Robert
Department of Thoracic and Cardiovascular Surgery, Trousseau University Hospital, Tours, France.
J Vasc Surg Cases Innov Tech. 2018 Dec 4;4(4):296-300. doi: 10.1016/j.jvscit.2018.08.003. eCollection 2018 Dec.
Aortic infection is a challenging condition. Fortunately, surgical revision of infected aorta with in situ reconstruction can provide long-term cure. The material for aortic repair remains an area of debate. The Omniflow II (LeMaitre Vascular, Burlington, Mass) prosthesis is a biosynthetic graft made to resist long-term degeneration and allows growth of host tissue with reduction of the risk of arterial infection. It has already been used for peripheral bypass with very low infection rates. Herein, we describe an original case of first-line native aorta replacement by a straight Omniflow II biologic prosthesis for infected aortic aneurysm.
主动脉感染是一种具有挑战性的病症。幸运的是,对感染的主动脉进行原位重建的手术翻修可实现长期治愈。主动脉修复材料仍是一个存在争议的领域。Omniflow II(LeMaitre Vascular,马萨诸塞州伯灵顿)假体是一种生物合成移植物,旨在抵抗长期退变,并允许宿主组织生长,同时降低动脉感染风险。它已被用于外周旁路手术,感染率极低。在此,我们描述了一例使用直管状Omniflow II生物假体对感染性主动脉瘤进行一线原位主动脉置换的原始病例。